Results 101 to 110 of about 20,539 (229)

Interstitial lung disease (ILD) and severe ITP

, 2007
Introduction: Platelets play an important role in inflammatory and immune responses. We report interstitial lung disease (ILD) developing during the acute phase of severe thrombocytopenia in 3 patients with severe refractory ITP.
Ahn, Yeon S, Fontana, Vincenzo, Donna, Elio, Horstman, Lawrence L, Dudkiewicz, Pamela, Ahn, Eugene R   +5 more
core   +1 more source

Chronic Respiratory Diseases in the 2023‐Defined WHO Western Pacific Region: Burden and Trends From GBD 2023

Med Research, EarlyView.
Chronic respiratory disease burden in the 2023‐defined WHO Western Pacific Region, 1990–2023: Using the Global Burden of Disease 2023 estimates, this study characterized the incidence, prevalence, deaths, and disability‐adjusted life years (DALYs) associated with chronic respiratory diseases (CRDs) in the 37 WHO Western Pacific Region Member States and
Zhang Yue, Yi‐Cheng Fu, Wen Zuo, Li‐Na Wang, Xing‐Xing Suo, Peng Sun, Jin‐Hui Bian, Ming‐Yan Wang   +7 more
wiley   +1 more source

[¹²³I]-Meta-Iodobenzylguanidine Scintigraphy in Sarcoidosis: Exploring Cardiac Autonomic Dysfunction in Patients with Unexplained Cardiac Symptoms

Diagnostics
Background/Objectives: Sarcoidosis is a systemic inflammatory disease that can cause cardiac autonomic dysfunction (SCAD), often underrecognized despite its clinical importance.
Lisette R. M. Raasing, Marjolein Drent, Ruth G. M. Keijsers, Andor F. van den Hoven, Marco C. Post, Jan C. Grutters, Marcel Veltkamp   +6 more
doaj   +1 more source

Emerging Approaches for Phytoconstituent Delivery in the Management of Rheumatoid Arthritis: Bridging Nature and Nanotechnology

Phytotherapy Research, EarlyView.
ABSTRACT Rheumatoid arthritis (RA) is an autoimmune condition marked by joint inflammation, cartilage destruction, and bone damage. Conventional treatments, including NSAIDs and DMARDs, have shown effectiveness in slowing down disease progression, but prolonged exposure to such medications results in adverse effects and lack of tolerance among patients.
Yogesh Khairnar, Sakshi Priya, Madhavi Rajpara, Venkatesh K. P. Rao, Geeta Bhatt, Gautam Singhvi   +5 more
wiley   +1 more source

Asymptomatic and slowly progressive anti-MDA5 ILD: A report of three cases deviating from a notoriously rapidly progressive ILD

Anti-melanoma differentiation-associated gene 5-positive (anti-MDA5) dermatomyositis (DM) is a rare autoimmune disease associated with rapidly-progressive interstitial lung disease (RP-ILD.) The reported morbidity and 6-month mortality remains high from ...
Koch, Abigail L., Schettino, Christopher, Schettino, Chris, Puthumana, Rose M., Vehar, Susan J.   +4 more
core   +1 more source

Pregnancy in CTD‐interstitial lung disease: Current evidence, clinical challenges, and a proposed management algorithm

Rheumatology &Autoimmunity, EarlyView.
Summary of pregnancy management in CTD‐ILD across preconception, antenatal, and postpartum phases, emphasizing risk stratification and multidisciplinary care. 6MWT, 6‐min walk test; CTD‐ILD: connective tissue disease‐interstitial lung disease; DLCO, diffusion capacity of the lung for carbon monoxide; FVC, forced vital capacity; MDT, multidisciplinary ...
Khaled Aldhuaina, Ghaydaa Aldabie, Mohammad Abdulsalam, Ali Jawad   +3 more
wiley   +1 more source

Restoring immune balance with low‐dose interleukin‐2 in a patient with anti‐synthetase syndrome and recurrent infections: A case report

Rheumatology &Autoimmunity, EarlyView.
This figure summarizes the clinical course and immune reconstitution in a patient with anti‐synthetase syndrome (ASyS) and recurrent refractory infections. Left panel: conventional immunosuppression is associated with marked Treg deficiency and persistent infections. Middle panel: intervention with subcutaneous low‐dose interleukin (IL)−2. Right panel:
Tian Gao, Yuxi Wang, Xiaojing Jiang, Yang Yun, Qinyi Su, Zhe Zhao, Qi Wu, Han Zhang, Shengxiao Zhang   +8 more
wiley   +1 more source

Updates in Diagnostic Tools for ILD

Journal of Clinical Medicine
Interstitial lung disease (ILD) is a group of diffuse parenchymal disorders, which are diagnosed in many cases by multidisciplinary discussion (MDD). In some cases, diagnosis can be challenging, and the addition of histopathology can increase diagnostic confidence. The tools to obtain a histopathological sample to diagnose ILD are expanding.
Arsal Tharwani, Manuel L. Ribeiro Neto
openaire   +2 more sources

Contemporary Fibrotic Interstitial Lung Disease Outcomes: A Multicentre National Cohort Study

Respirology, EarlyView.
This study determined contemporary transplant‐free survival in fibrotic interstitial lung disease (ILD), identified baseline factors associated with death or transplant, and assessed performance of the ILD‐GAP (Gender, Age, Physiology) index in a contemporary cohort.
Tyler Pitre, Christopher J. Ryerson, Shaun Ong, Kerri A. Johannson, Deborah Assayag, Veronica Marcoux, Martin Kolb, Helene Manganas, Daniel‐Costin Marinescu, Jolene H. Fisher   +9 more
wiley   +1 more source

Systemic Autoimmune Rheumatic Diseases and ILD

Systemic Autoimmune Rheumatic Diseases and ILD. Damanpaul Sondhi, MD, RRH Pulmonary Medicine; Ya Li Chen, MD, RRH Rheumatology; Benjamin Fleming, MD, RGH Pulmonary Medicine Fellow Objectives: Discuss updates on immunotherapy in ILD from ACR updates ...
Chen, Ya Li, Fleming, Benjamin, Sondhi, Damanpaul S   +2 more
core